Search Results

Displaying Results 7176-7200 of 11038 "'T'"

Feb 19, 2026, 08:03 ET THE TUDOR RANGER LINEUP EXPANDS

6, 9 and 12 o'clock, whilst incorporating new state-of-the-art technical elements, in particular a high-performance Manufacture Calibre and a TUDOR "T-fit" clasp with a rapid adjustment system. It continues, within the TUDOR collection, the tradition of the expedition watch, born with the Oyster Prince

More news about: TUDOR


Feb 19, 2026, 08:02 ET Liviniti Promotes In-depth Understanding of PBM Transparency

The discussion includes techniques and resources to assess value in PBM business models across the industry.Leading the discussion are Steven T. Boyd, PharmD, Liviniti EVP and Cathy Fladeland, Sr. Director. Both have extensive experience in the PBM and broker space with deep knowledge of market

More news about: Liviniti


Feb 19, 2026, 07:33 ET Vie Ventures Names Jeff Bluestone, PhD, as Managing Director

targeting T-cell co-stimulation and immune checkpoints. He previously served as founding Director of the Immune Tolerance Network, founding CEO of the Parker Institute for Cancer Immunotherapy, and most recently co-founded and led Sonoma Biotherapeutics, a company focused on engineered regulatory T-cell therapies.

More news about: Vie Ventures


Feb 19, 2026, 07:30 ET Safehold Named 2026 Ivory Prize Finalist for Affordable Housing Innovation

Investments Contact: Steve WylderHead of Investments T: 310.315.5566 E: [email protected]

More news about: Safehold


Feb 19, 2026, 06:15 ET Epson Robots to Exhibit at DesignCon, APEX and MAX in Early 2026

T-Series All-in-One SCARA robot – a cost-efficient, easy-to-set-up automation solution – alongside the

More news about: Epson America, Inc.


Feb 19, 2026, 05:26 ET KuCoin renforce sa stratégie de marque mondiale à long terme à travers un partenariat axé sur la confiance avec Tadej Pogačar

impressions. Au contraire, KuCoin évalue les partenariats sur la base de critères stratégiques à long terme :La collaboration renforce-t-elle la confiance ?Fait-elle progresser l'adoption responsable des cryptomonnaies ?Au-delà de l'impact marketing à court terme, l'entreprise

More news about: KuCoin


Feb 19, 2026, 03:26 ET Japón aprueba los fortificantes de Prolacta Bioscience, elaborados 100% con leche materna

infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 Datos

More news about: Prolacta Bioscience


Feb 19, 2026, 03:00 ET Heidrick & Struggles Appoints Two Managing Directors to Lead Interim Management Business in Germany

AtreusFrank WöllsteinWBCO [email protected]t +49 69 1338 8035m +49 171 489 7487

More news about: Heidrick & Struggles International, Inc.


Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 Data

More news about: Prolacta Bioscience


Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 Data

More news about: Prolacta Bioscience


Feb 19, 2026, 00:38 ET 'The Blue, The Gold, and The Gray' offers a sweeping perspective on America's formation, expansion and division

published nine additional books on American and Colorado history. His interest in the Civil War began through family research connected to Gen. William T. Sherman and Gen. Ulysses S. Grant, leading to a lifelong focus on American historical scholarship.EDITORS: For review

More news about: Archway Publishing


Feb 19, 2026, 00:00 ET Record High Median Securities Class Action Settlement Amount Amid Slower Settlement Activity in 2025

Dr. Laarni T. Bulan, a report co-author and vice president at Cornerstone Research. "The '33 Act-only cases were associated with a record high median number of

More news about: Cornerstone Research


Feb 19, 2026, 00:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

infants born in Japan and born to mothers of Japanese ethnicity in California. Sci Rep. 2025;15:9943. doi:10.1038/s41598-025-92393-yIsayama T. The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future. Transl Pediatr. 2019;8(3):199-211. doi:10.21037/tp.2019.07.10 Data

More news about: Prolacta Bioscience


Feb 18, 2026, 20:59 ET Ecopetrol announces the dates for the presentation of its fourth quarter and full-year 2025 results report and conference call

broadcast:https://xegmenta.co/ecopetrol/conferencia-de-resultados-4t-2025/Participants may ask questions via the platform once the call has begun.The earnings release, presentation,

More news about: Ecopetrol S.A.


Feb 18, 2026, 17:24 ET PAN GLOBAL GIBT BOHRPROGRAMME FÜR 2026 IN DEN PROJEKTEN ESCACENA UND CÁRMENES IN SPANIEN BEKANNT

KupferCañada HondaAbgeleitet: 5,0 Mt mit 0,65 g/t Au, 0,14 % Cu, 1,2 g/t Ag; 0,74 g/t AuEq (104 koz Au, 6,8 kt Cu, 0,2 Moz Ag) – bei einem Cutoff-Gehalt von 0,25 g/t Gold.Für weitere Informationen und zusätzliche technische Angaben verweisen wir

More news about: Pan Global Resources Inc.


Feb 18, 2026, 17:00 ET OceanaGold Reports Mineral Reserves and Resources for the Year Ended 2025

underground cut-off grade is 0.97 g/t Au.WaihiMartha underground cut-off grade is 2.15 g/t Au, Wharekirauponga cut-off grade is 1.70 g/t Au.Martha Open Pit cut-off grade is 0.5 g/t Au and Gladstone Open Pit cut-off grade is 0.56 g/t Au. About OceanaGoldOceanaGold

More news about: OceanaGold Corporation


Feb 18, 2026, 16:01 ET M&T Bank Corporation Announces First Quarter Common Stock Dividend

/PRNewswire/ -- M&T Bank Corporation ("M&T") (NYSE:MTB) announced that it has declared a quarterly cash dividend of $1.50 per share on its common stock. The dividend will be payable March 31, 2026, to shareholders of record at the close of business on March 2, 2026.About M&TM&T

More news about: M&T Bank Corporation


Feb 18, 2026, 15:41 ET La serie totalmente eléctrica de Toyota se amplía con el nuevo SUV bZ Woodland, robusto y potente

o hasta 3 GB después de la activación) que ofrece conectividad 4G para hasta cinco dispositivos, lo que convierte el bZ en un punto de acceso de AT&T.Además de la ya de por sí sólida oferta de capacidad de reproducción de audio con HD Radio, datos USB y una suscripción de prueba de 3 meses

More news about: Toyota Motor North America


Feb 18, 2026, 14:57 ET REGGAETÓN PIONEERS LUNY TUNES TO BE HONORED WITH THE BMI PRESIDENT'S AWARD AT THE 2026 BMI LATIN AWARDS

ensemble of music creators who have received the accolade in the past including benny blanco, Luis Fonsi, Ellie Goulding, Horacio Palencia, Pitbull, T-Pain and Wisin y Yandel, among others.Elena Rose is a Venezuelan American singer-songwriter who has emerged as one of Latin music's most sought-after

More news about: Broadcast Music, Inc. (BMI)


Feb 18, 2026, 14:30 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Therapeutic Opportunity. PLoS One. 2015 Jul 15;10(7):e0132011. doi: 10.1371/journal.pone.0132011. PMID: 26177518; PMCID: PMC4503742.5.      Lorant T, et al. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

More news about: Hansa Biopharma AB


Feb 18, 2026, 14:28 ET Hansa Biopharma's Biologics License Application (BLA) for imlifidase accepted by the FDA

Therapeutic Opportunity. PLoS One. 2015 Jul 15;10(7):e0132011. doi: 10.1371/journal.pone.0132011. PMID: 26177518; PMCID: PMC4503742.5.      Lorant T, et al. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.

More news about: Hansa Biopharma AB


Feb 18, 2026, 14:05 ET /C O R R E C T I O N -- Erlin.ai/

More news about: Erlin.ai


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.